Literature DB >> 3488841

Surveillance of meningococcal infections and other forms of purulent meningitis: a 4-year study in the USSR.

A A Demina, V I Pokrovskij, T I Iljina, L I Larina, N P Devjatkina.   

Abstract

The laboratory examination, by microscopic or bacteriological methods and by counterimmunoelectrophoresis, of CSF and blood from 2653 patients with purulent bacterial meningitis, including those with clinically diagnosed meningococcal infection, was carried out between June 1980 and June 1984. The results showed three main etiological agents: meningococci (79.9%), pneumococci (10.8%) and Haemophilus influenzae type b (5.25%). Out of 488 Neisseria meningitidis strains isolated from the CSF or blood, 58.2% belonged to serogroup A, 17.2% to serogroup B, and 14% to serogroup C; infection due to the B serogroup reached nearly 59% among children in 1984. Serotypes were determined in 131 out of 151 strains of Streptococcus pneumoniae and the most frequent were types 1, 19 and 3; type 34, which was isolated from 4 patients, is not a component of the pneumococcal vaccine. The age groups at high risk were children under 5 years old (for meningococcal infection), adults and babies in the first year (pneumococcal meningitis), and children under 3 years, especially between 6 months and 2 years old (H.influenzae type b infection).

Entities:  

Mesh:

Year:  1986        PMID: 3488841      PMCID: PMC2490945     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  10 in total

1.  Serotypes of Neisseria meningitidis isolated from patients in Norway during the first six months of 1978.

Authors:  E Holten
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

2.  [Epidemiologic aspects of purulent meningitis in tropical Africa (1052 cases observed in Dakar)].

Authors:  M Rey; C Lafaix; I D Mar; C Trevoux
Journal:  Lyon Med       Date:  1972-11-26

3.  Meningitis diagnostic bacteriology.

Authors:  W R Sanborn
Journal:  J Egypt Public Health Assoc       Date:  1969

Review 4.  Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups.

Authors:  J B Robbins; R Austrian; C J Lee; S C Rastogi; G Schiffman; J Henrichsen; P H Mäkelä; C V Broome; R R Facklam; R H Tiesjema
Journal:  J Infect Dis       Date:  1983-12       Impact factor: 5.226

5.  Serotypes and polyacrylamide gel electrophoresis types among disease-associated isolates of group B Neisseria meningitidis in Spain, 1976-1979.

Authors:  L F Mocca; G del Real; C E Frasch
Journal:  J Infect Dis       Date:  1983-08       Impact factor: 5.226

6.  [Multicenter study of pneumococcal serotypes in Africa].

Authors:  F A Denis; B D Greenwood; J L Rey; M Prince-David; S Mboup; N Lloyd-Evans; K Williams; I Benbachir; N El Ndaghri; D Hansman
Journal:  Bull World Health Organ       Date:  1983       Impact factor: 9.408

7.  Antibiotic resistance in pathogenic bacteria.

Authors:  M T Parker
Journal:  WHO Chron       Date:  1982

8.  Meningococcal infections. 2. Field trial of group C meningococcal polysaccharide vaccine in 1969-70.

Authors:  R Gold; M S Artenstein
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

Review 9.  Community-acquired purulent meningitis: a review of 1,316 cases during the antibiotic era, 1954-1976.

Authors:  P J Geiseler; K E Nelson; S Levin; K T Reddi; V K Moses
Journal:  Rev Infect Dis       Date:  1980 Sep-Oct

10.  Acute bacterial meningitis in Cairo, Arab Republic of Egypt, 1 January 1971 through 31 December 1975.

Authors:  W F Miner; D C Edman
Journal:  Am J Trop Med Hyg       Date:  1978-09       Impact factor: 2.345

  10 in total
  1 in total

Review 1.  An epidemiological review of changes in meningococcal biology during the last 100 years.

Authors:  Anne Abio; Keith R Neal; Charles R Beck
Journal:  Pathog Glob Health       Date:  2013-12-19       Impact factor: 2.894

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.